Bioarctic Neuroscience AB
Records under this name other than the patents Bioarctic Neuroscience AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
Showing 1 to 10 of 10 · Back to Bioarctic Neuroscience AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,025,878 | Protofibril Selective Antibodies and the Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,084,832 | Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,573,994 | Abeta PROTOFIBRIL BINDING ANTIBODIES Formerly held In force · High confidence | In force | High confidence | |
| US 8,404,459 | Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof Term ended Term ended Jun 21, 2025 · USPTO record | Term ended | Term ended Jun 21, 2025 | USPTO record |
| US 8,999,936 | Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof Term ended Ended no later than Jun 21, 2025 · USPTO record | Term ended | Ended no later than Jun 21, 2025 | USPTO record |
| US 9,895,234 | Spinal cord devices and methods for promoting axonal regeneration Lapsed on the fee record Ended Feb 20, 2022 · USPTO record | Lapsed on the fee record | Ended Feb 20, 2022 | USPTO record |
| US 7,700,719 | Arctic β amyloid protofibril Term ended Term ended Oct 17, 2021 · USPTO record | Term ended | Term ended Oct 17, 2021 | USPTO record |
| US 7,179,463 | Treatment of alzheimer's disease Term ended Term ended Jul 9, 2021 · USPTO record | Term ended | Term ended Jul 9, 2021 | USPTO record |
| US 8,409,575 | Antibodies specific for amyloid beta protofibril Term ended Ended no later than Jul 9, 2021 · USPTO record | Term ended | Ended no later than Jul 9, 2021 | USPTO record |
| US 7,709,695 | Transgenic mouse expressing arctic mutation E693G Lapsed on the fee record Ended May 4, 2018 · USPTO record | Lapsed on the fee record | Ended May 4, 2018 | USPTO record |